An in vivo protective response against toxic effects of the dermonecrotic protein from Loxosceles intermedia spider venom elicited by synthetic epitopes

Vaccine

Volumn 27, Issue 31, 2009, Pages 4201-4208

  Felicori, Liza ^a,b   Fernandes, Paula B ^a   Giusta, Mario S ^a   Duarte, Clara G ^a   Kalapothakis, Evanguedes ^a   Nguyen, Christophe ^b   Molina, Frank ^b   Granier, Claude ^b   Chávez Olórtegui, Carlos ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b CNRS UMR3145 Cap Delta Parc Euromédecine   (France)

Author keywords

Antivenom; Epitope mapping; Loxosceles venom; Loxtox; Neutralization; Recombinant protein; Synthetic peptides; Vaccine

Indexed keywords

EPITOPE; PROTEIN LID1; RECOMBINANT PROTEIN; SPIDER VENOM; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BLEEDING; CONTROLLED STUDY; CROSS REACTION; EDEMA; EPITOPE MAPPING; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IN VIVO STUDY; LOXOSCELISM; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RABBIT; SKIN NECROSIS; SPIDER BITE;

ANIMALS; EDEMA; EPITOPE MAPPING; EPITOPES; FEMALE; HEMORRHAGE; INSECT BITES AND STINGS; NECROSIS; PHOSPHORIC DIESTER HYDROLASES; RABBITS; SPIDER VENOMS; SPIDERS; VACCINES, SYNTHETIC;

EID: 67349128350     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.04.038     Document Type: Article

References (49)

1. Eickstedt VRD. Aranhas de importância médica no Brasil. Cap. 11, p. 151-172. Barravieira B (Ed.). Venenos animais: uma visão integrada. Rio de Janeiro, 1994.
2. Goncalves-de-Andrade R.M., and Tambourgi D.V. First record on Loxosceles laeta (Nicolet, 1849) (Araneae, Sicariidae) in the West Zone of Sao Paulo City, Sao Paulo, Brazil, and considerations regarding its geographic distribution. Rev Soc Bras Med Trop 36 3 (2003) 425-426
3. Pauli I., Puka J., Gubert I.C., and Minozzo J.C. The efficacy of antivenom in loxoscelism treatment. Toxicon 48 2 (2006) 123-137
4. Futrell J.M. Loxoscelism. Am J Med Sci 304 4 (1992) 261-267
5. Schenone H. Cutaneous loxoscelism with edematous predominance. Bol Chil Parasitol 53 3-4 (1998) 78-83
6. Tambourgi D.V., Paixao-Cavalcante D., Goncalves de Andrade R.M., Fernandes-Pedrosa Mde F., Magnoli F.C., Paul Morgan B., et al. Loxosceles sphingomyelinase induces complement-dependent dermonecrosis, neutrophil infiltration, and endogenous gelatinase expression. J Invest Dermatol 124 4 (2005) 725-731
7. Ribeiro R.O., Chaim O.M., da Silveira R.B., Gremski L.H., Sade Y.B., Paludo K.S., et al. Biological and structural comparison of recombinant phospholipase D toxins from Loxosceles intermedia (brown spider) venom. Toxicon 50 8 (2007) 1162-1174
8. Kalapothakis E., Chatzaki M., Goncalves-Dornelas H., de Castro C.S., Silvestre F.G., Laborne F.V., et al. The Loxtox protein family in Loxosceles intermedia (Mello-Leitao) venom. Toxicon 50 7 (2007) 938-946
9. Abdulkader R.C., Barbaro K.C., Barros E.J., and Burdmann E.A. Nephrotoxicity of insect and spider venoms in Latin America. Semin Nephrol 28 4 (2008) 373-382
10. da Silveira R.B., dos Santos Filho J.F., Mangili O.C., Veiga S.S., Gremski W., Nader H.B., et al. Identification of proteases in the extract of venom glands from brown spiders. Toxicon 40 6 (2002) 815-822
11. de Castro C.S., Silvestre F.G., Araujo S.C., Gabriel de M.Y., Mangili O.C., Cruz I., et al. Identification and molecular cloning of insecticidal toxins from the venom of the brown spider Loxosceles intermedia. Toxicon 44 3 (2004) 273-280
12. Machado L.F., Laugesen S., Botelho E.D., Ricart C.A., Fontes W., Barbaro K.C., et al. Proteome analysis of brown spider venom: identification of loxnecrogin isoforms in Loxosceles gaucho venom. Proteomics 5 8 (2005) 2167-2176
13. Chaim O.M., Sade Y.B., da Silveira R.B., Toma L., Kalapothakis E., Chavez-Olortegui C., et al. Brown spider dermonecrotic toxin directly induces nephrotoxicity. Toxicol Appl Pharmacol 211 1 (2006) 64-77
14. Ramos-Cerrillo B., Olvera A., Odell G.V., Zamudio F., Paniagua-Solis J., Alagon A., et al. Genetic and enzymatic characterization of sphingomyelinase D isoforms from the North American fiddleback spiders Loxosceles boneti and Loxosceles reclusa. Toxicon 44 5 (2004) 507-514
15. Cunha R.B., Barbaro K.C., Muramatsu D., Portaro F.C., Fontes W., and de Sousa M.V. Purification and characterization of loxnecrogin, a dermonecrotic toxin from Loxosceles gaucho brown spider venom. J Protein Chem 22 2 (2003) 135-146
16. Kalapothakis E., Araujo S.C., de Castro C.S., Mendes T.M., Gomez M.V., Mangili O.C., et al. Molecular cloning, expression and immunological properties of LiD1, a protein from the dermonecrotic family of Loxosceles intermedia spider venom. Toxicon 40 12 (2002) 1691-1699
17. Hogan C.J., Barbaro K.C., and Winkel K. Loxoscelism: old obstacles, new directions. Ann Emerg Med 44 6 (2004) 608-624
18. Felicori L., Araujo S.C., de Avila R.A., Sanchez E.F., Granier C., Kalapothakis E., et al. Functional characterization and epitope analysis of a recombinant dermonecrotic protein from Loxosceles intermedia spider. Toxicon 48 5 (2006) 509-519
19. Olvera A., Ramos-Cerrillo B., Estevez J., Clement H., de Roodt A., Paniagua-Solis J., et al. North and South American Loxosceles spiders: development of a polyvalent antivenom with recombinant sphingomyelinases D as antigens. Toxicon 48 1 (2006) 64-74
20. Guilherme P., Fernandes I., and Barbaro K.C. Neutralization of dermonecrotic and lethal activities and differences among 32-35 kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies. Toxicon 39 9 (2001) 1333-1342
21. Bijker M.S., Melief C.J., Offringa R., and van der Burg S.H. Design and development of synthetic peptide vaccines: past, present and future. Expert Rev Vaccines 6 4 (2007) 591-603
22. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 1 (1951) 265-275
23. Braz A., Minozzo J., Abreu J.C., Gubert I.C., and Chavez-Olortegui C. Development and evaluation of the neutralizing capacity of horse antivenom against the Brazilian spider Loxosceles intermedia. Toxicon 37 9 (1999) 1323-1328
24. Chang H.T., Pai T.W., Fan T.C., Su B.H., Wu P.C., Tang C.Y., et al. A reinforced merging methodology for mapping unique peptide motifs in members of protein families. BMC Bioinformatics 7 (2006) 38
25. Laune D., Molina F., Ferrieres G., Villard S., Bes C., Rieunier F., et al. Application of the Spot method to the identification of peptides and amino acids from the antibody paratope that contribute to antigen binding. J Immunol Methods 267 1 (2002) 53-70
26. Chavez-Olortegui C., Amara D.A., Rochat H., Diniz C., and Granier C. In vivo protection against scorpion toxins by liposomal immunization. Vaccine 9 12 (1991) 907-910
27. Furlanetto WB RS, Rosa RR, Saliba F, Navas J. Observação dos efeitos do veneno loxoscélico e avaliação da sua atividade. Ciênc Cult 1962;14:252.
28. Ey P.L., Prowse S.J., and Jenkin C.R. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry 15 7 (1978) 429-436
29. Guex N., and Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18 15 (1997) 2714-2723
30. Murakami M.T., Fernandes-Pedrosa M.F., Tambourgi D.V., and Arni R.K. Structural basis for metal ion coordination and the catalytic mechanism of sphingomyelinases D. J Biol Chem 280 14 (2005) 13658-13664
31. Marti-Renom M.A., Stuart A.C., Fiser A., Sanchez R., Melo F., and Sali A. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 29 (2000) 291-325
32. Sams H.H., Dunnick C.A., Smith M.L., and King Jr. L.E. Necrotic arachnidism. J Am Acad Dermatol 44 4 (2001) 561-573 quiz 73-6
33. Wendell R.P. Brown recluse spiders: a review to help guide physicians in nonendemic areas. South Med J 96 5 (2003) 486-490
34. Swanson D.L., and Vetter R.S. Loxoscelism. Clin Dermatol 24 3 (2006) 213-221
35. Rees R., Shack R.B., Withers E., Madden J., Franklin J., and Lynch J.B. Management of the brown recluse spider bite. Plast Reconstr Surg 68 5 (1981) 768-773
36. Gomez H.F., Miller M.J., Trachy J.W., Marks R.M., and Warren J.S. Intradermal anti-loxosceles Fab fragments attenuate dermonecrotic arachnidism. Acad Emerg Med 6 12 (1999) 1195-1202
37. Toro A.F., Malta M.B., Soares S.L., Da Rocha G.C., da Silva Lira M., De Oliveira T.A., et al. Role of IgG(T) and IgGa isotypes obtained from arachnidic antivenom to neutralize toxic activities of Loxosceles gaucho, Phoneutria nigriventer and Tityus serrulatus venoms. Toxicon 48 6 (2006) 649-661
38. Machado de Avila R.A., Alvarenga L.M., Tavares C.A., Molina F., Granier C., and Chavez-Olortegui C. Molecular characterization of protective antibodies raised in mice by Tityus serrulatus scorpion venom toxins conjugated to bovine serum albumin. Toxicon 44 3 (2004) 233-241
39. Araujo S.C., Castanheira P., Alvarenga L.M., Mangili O.C., Kalapothakis E., and Chavez-Olortegui C. Protection against dermonecrotic and lethal activities of Loxosceles intermedia spider venom by immunization with a fused recombinant protein. Toxicon 41 3 (2003) 261-267
40. Chavez-Olortegui C., Kalapothakis E., Ferreira A.M., Ferreira A.P., and Diniz C.R. Neutralizing capacity of antibodies elicited by a non-toxic protein purified from the venom of the scorpion Tityus serrulatus. Toxicon 35 2 (1997) 213-221
41. Srairi-Abid N., Mansuelle P., Mejri T., Karoui H., Rochat H., Sampieri F., et al. Purification, characterization and molecular modelling of two toxin-like proteins from the Androctonus australis Hector venom. Eur J Biochem 267 17 (2000) 5614-5620
42. Maria W.S., Velarde D.T., Alvarenga L.M., Nguyen C., Villard S., Granier C., et al. Localization of epitopes in the toxins of Tityus serrulatus scorpions and neutralizing potential of therapeutic antivenoms. Toxicon 46 2 (2005) 210-217
43. Alvarenga L.M., Diniz C.R., Granier C., and Chavez-Olortegui C. Induction of neutralizing antibodies against Tityus serrulatus scorpion toxins by immunization with a mixture of defined synthetic epitopes. Toxicon 40 1 (2002) 89-95
44. Calderon-Aranda E.S., Olamendi-Portugal T., and Possani L.D. The use of synthetic peptides can be a misleading approach to generate vaccines against scorpion toxins. Vaccine 13 13 (1995) 1198-1206
45. Blythe M.J., and Flower D.R. Benchmarking B cell epitope prediction: underperformance of existing methods. Protein Sci 14 1 (2005) 246-248
46. Van Regenmortel M.H. Immunoinformatics may lead to a reappraisal of the nature of B cell epitopes and of the feasibility of synthetic peptide vaccines. J Mol Recognit 19 3 (2006) 183-187
47. Schunk M.K., and Macallum G.E. Applications and optimization of immunization procedures. Ilar J 46 3 (2005) 241-257
48. Chen S.W., Van Regenmortel M.H., and Pellequer J.L. Structure-activity relationships in Peptide-antibody complexes: implications for epitope prediction and development of synthetic Peptide vaccines. Curr Med Chem 16 8 (2009) 953-964
49. Moreau V., Fleury C., Piquer D., Nguyen C., Novali N., Villard S., et al. PEPOP: computational design of immunogenic peptides. BMC Bioinformatics 9 (2008) 71